ADMA
ADMA Biologics (ADMA) Investor Questions
Review ADMA Biologics (ADMA) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- ADMA Biologics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 63
- Annual revenue
- $510.17M
- Annual net income
- $146.93M
- Annual free cash flow
- $27.50M
ADMA Biologics (ADMA) Investor Questions research
ADMA Biologics trades under the ticker ADMA. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ADMA through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.